Skip to main content

Table 2 Diabetes management and diabetes-related complications in individuals with WRS

From: Diabetes management in Wolcott-Rallison syndrome: analysis from the German/Austrian DPV database

 

n data available

median [Q1-Q3] or %

Manifestation with diabetic ketoacidosis

10

70

Insulin dose at manifestation (IU/kg/d)

6

0.7 [0.5–0.9]

Insulin dose at follow-up (IU/kg/d)

11

0.7 [0.5–1]

HbA1c at manifestation (%)

5

7 [5.8–10.9]

HbA1c at follow-up (%)

11

8 [7–9]

≥ 1 episodes of SH during follow-up

10

40

≥ 1 episodes of DKA during follow-up

10

10